Changeflow GovPing Healthcare Cryolysis Adipose Tissue Sleep Apnea Treatment ...
Routine Notice Added Final

Cryolysis Adipose Tissue Sleep Apnea Treatment Patent Application

Email

Summary

USPTO published patent application US20260096922A1 for methods, devices, and systems utilizing cryolysis of oropharyngeal adipose tissues to selectively remove fat cells causing obstructive sleep apnea. The application was filed December 10, 2025, by inventors Donald A. Gonzales and Anthony Natale, and published April 9, 2026. The invention employs a chilled liquid applied to target tissue at temperatures and durations sufficient to cause cryolysis.

What changed

USPTO published patent application US20260096922A1 for cryolysis apparatus and methods to treat obstructive sleep apnea by selectively removing fat cells from oropharyngeal tissues. The application covers a chilled liquid delivery system applied to target tissue at cryolytic temperatures and durations.

For parties developing medical devices or treatments for sleep apnea, this published application indicates potential future IP rights that could affect freedom to operate in this technology space. Patent applications are publicly available for review and comment, though no third-party participation is required at this stage.

What to do next

  1. Monitor for patent grant status
  2. Review claims for freedom-to-operate analysis

Archived snapshot

Apr 13, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

APPARATUS AND METHODS FOR TREATMENT OF OBSTRUCTIVE SLEEP APNEA UTILIZING CRYOLYSIS OF ADIPOSE TISSUES

Application US20260096922A1 Kind: A1 Apr 09, 2026

Inventors

Donald A. GONZALES, Anthony NATALE

Abstract

Methods, devices, and systems employ cryolysis of oropharyngeal adipose tissues to selectively remove fat cells from the tissues causing obstructive sleep apnea. In various embodiments, a chilled liquid—e.g., a liquid or air—is applied to the target tissue at a temperature and for a duration sufficient to cause cryolysis.

CPC Classifications

A61F 7/12 A61B 18/02 A61B 2018/00172 A61B 2018/00291 A61B 2018/00327 A61B 2018/00464 A61B 2018/00642 A61B 2018/00714 A61B 2018/00791 A61B 2018/0212 A61B 2018/0262 A61B 2018/0293 A61F 2007/001 A61F 2007/0063 A61F 2007/0096

Filing Date

2025-12-10

Application No.

19415549

View original document →

Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260096922A1

Who this affects

Applies to
Medical device makers Healthcare providers Investors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device patents Cryotherapy treatment methods Sleep apnea devices
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!